Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003821
Filing Date
2024-02-14
Accepted
2024-02-14 18:44:45
Documents
1
Period of Report
2024-02-13

Document Format Files

Seq Description Document Type Size
1 form4-02142024_110233.html 4  
1 form4-02142024_110233.xml 4 5997
  Complete submission text file 0001415889-24-003821.txt   7543
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Szela Mary T (Reporting) CIK: 0001410289 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39813 | Film No.: 24641329

Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)